Figure 1.
Figure 2.
Figure 3.
Figure 4.
Figure 5.
Figure 6.
Figure 7.
Figure 8.
Distribution of the patients according to postoperative Stage
| variable | n(%) |
|---|---|
| STAGE | |
| 0 | 4(2,62) |
| I | 9(5,92) |
| II A | 35(23,02) |
| II B | 2(1,32) |
| II C | 2(1,32) |
| III A | 1(0,66) |
| III B | 54(35,53) |
| III C | 32(21,05) |
| IV A | 7(4,61) |
| IV C | 6(3,95) |
Demographic characteristics of the patients
| variable | n (%) |
|---|---|
| Gender | |
| female | 54 (35.53) |
| male | 98 (64.47) |
| Age groups | |
| ≤50 years | 15 (9.87) |
| >50 years | 137 (90.13) |
| Age/years | |
| (mean ± SD)( min-max) | (68.37 ± 11.3)(34 – 89) |
| median (IQR) | 75.5(62 – 11.32) |
Immunohistochemical stains
| Antibody(rtu) | Clone | Producer | Type of signal |
|---|---|---|---|
| MLH1 | M1 | Ventana, USA | nuclear |
| PMS2 | A16-4 | Ventana, USA | nuclear |
| MSH2 | G219-1129 | Ventana, USA | nuclear |
| MSH6 | SP93 | Ventana, USA | nuclear |
| PDL1 | SP263 | Ventana, USA | membranous |
| HER2 | 4B5 | Ventana, USA | membranous |